Relation between on-treatment increments in serum high-density lipoprotein cholesterol levels and cardiac mortality in patients with coronary heart disease (from the Bezafibrate Infarction Prevention trial).

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples